Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-31

FDA Approved: PAROXETINE — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

FDA approved a supplemental application for a generic paroxetine hydrochloride product submitted by NorthStar Rx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PAROXETINE HYDROCHLORIDE (Paroxetine hydrochloride)
  • Paroxetine (Paroxetine hydrochloride)

Snippet

SUPPL AP for PAROXETINE (PAROXETINE HYDROCHLORIDE)